- Home
- TWN vs PSTX Comparison
TWN vs PSTX Comparison
Compare TWN & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWN
- PSTX
- Stock Information
- Founded
- TWN 1986
- PSTX 2014
- Country
- TWN Hong Kong
- PSTX United States
- Employees
- TWN N/A
- PSTX N/A
- Industry
- TWN Trusts Except Educational Religious and Charitable
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWN Finance
- PSTX Health Care
- Exchange
- TWN Nasdaq
- PSTX Nasdaq
- Market Cap
- TWN 313.8M
- PSTX 249.1M
- IPO Year
- TWN N/A
- PSTX 2020
- Fundamental
- Price
- TWN $45.85
- PSTX $2.50
- Analyst Decision
- TWN
- PSTX Strong Buy
- Analyst Count
- TWN 0
- PSTX 2
- Target Price
- TWN N/A
- PSTX $15.00
- AVG Volume (30 Days)
- TWN 20.1K
- PSTX 539.2K
- Earning Date
- TWN 01-01-0001
- PSTX 11-07-2024
- Dividend Yield
- TWN 1.10%
- PSTX N/A
- EPS Growth
- TWN N/A
- PSTX N/A
- EPS
- TWN N/A
- PSTX N/A
- Revenue
- TWN N/A
- PSTX $88,462,000.00
- Revenue This Year
- TWN N/A
- PSTX $36.53
- Revenue Next Year
- TWN N/A
- PSTX N/A
- P/E Ratio
- TWN N/A
- PSTX N/A
- Revenue Growth
- TWN N/A
- PSTX N/A
- 52 Week Low
- TWN $25.22
- PSTX $1.83
- 52 Week High
- TWN $41.51
- PSTX $4.27
- Technical
- Relative Strength Index (RSI)
- TWN 63.60
- PSTX 38.80
- Support Level
- TWN $43.82
- PSTX $2.41
- Resistance Level
- TWN $45.52
- PSTX $2.61
- Average True Range (ATR)
- TWN 0.88
- PSTX 0.11
- MACD
- TWN 0.14
- PSTX -0.00
- Stochastic Oscillator
- TWN 96.02
- PSTX 32.14
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.